*** Need an answer to your GCP query ? Post your query at HelpDesk ***
Follow us on




New Chemical Entity (NCE)

A drug that contains no active moiety that has been approved by the FDA in any other application submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act. An NCE is a molecule developed by the innovator company in the early drug discovery stage, which after undergoing clinical trials could translate into a drug that could be a cure for some disease. Synthesis of an NCE is the first step in the process of drug development.

Frequently Asked Questions
    Adverse Events & Serious Adverse Events
    Archiving
    Bioavailability and Bioequivalence
    Clinical Trial Supplies/IMP
    Computer Questions and Internet
    Confidentiality
    Consent of Investigator/1572 and CVs
    Fraud
    GCP Essential Documents | gcp investigator brochure - GCPHelpdesk
    Generic Drugs
    Herbal Products
    Informed Consent and Patient Information Sheet
    Insurance and Liability
    Investigator and Investigator Site
    Laboratory
    Phases of Trial
    Protocol and Study Design
    Quality Assurance and Audits
    Source Document Verification
     

    Opinion Poll

    What do you think, which of following is the major factor at site likely to impact data Quality?
     
    This opinion poll provides an informal way for the clinical research community to express its views on current topics. The results are not a scientific poll and do not necessarily reflect the percentages of all clinical researchers who agree with these positions.

    Links